RN-administered infusions under MD/DO protocol oversight · USP <797> & 503B sourcing standards dispatch@ivconnection.com
Connection

Rate-controlled coenzyme infusion

NAD+ IV Infusion Protocol (250 mg to 1,000 mg)

NAD+ (nicotinamide adenine dinucleotide) infusions are the longest and most expensive drip on most menus because the dose has to run slowly, usually over two to four hours, to avoid chest pressure, cramping and nausea. This page covers the formulation, how titration works dose by dose, what is and is not known about cellular effects, and what sessions and packages cost. NAD+ is a compounded product with no FDA-approved indication, and human outcome data for IV use are limited.

  • Dose range250–1,000 mg
  • Infusion time2–4 hours
  • Lounge$375–$850
  • Mobile$450–$1,100
Patient resting at home during an IV infusion

Exact standard formulation

Typical adult NAD+ infusion setup; dose, volume and rate are set by the medical director
IngredientTypical doseMechanism of actionOsmolarity contribution
NAD+ (β-nicotinamide adenine dinucleotide), compounded vial250, 500, 750 or 1,000 mg per sessionRedox coenzyme (NAD+/NADH) for glycolysis, the TCA cycle and oxidative phosphorylation; co-substrate for sirtuins, PARP DNA-repair enzymes and CD38Small: ≈ 1.5 mOsm per 500 mg (molecular weight ≈ 663)
Carrier: 0.9% NaCl250–1,000 mL (larger doses in larger volume)Dilutes NAD+ so rate can be finely controlled by drip count or pump308 mOsm/L; final bag stays ≈ 308–315 mOsm/L
Optional: Lactated Ringer’s carrier500–1,000 mLUsed by some protocols for patients who also want rehydration; confirm compatibility with the compounding pharmacy≈ 273 mOsm/L
Optional: glutathione slow push after NAD+600–2,000 mg, separate syringeThiol antioxidant given after the NAD+ bag finishes; not mixed into the NAD+ bag≈ 6–7 mOsm per gram (buffered); hypertonic in the syringe
Optional: B12 IM injection1,000 mcg hydroxocobalamin or methylcobalaminMethylation and energy-metabolism cofactor, given intramuscularlyNot in the bag

Cellular bioenergetics and sirtuins: what is known

NAD+ is a coenzyme present in every cell. It shuttles electrons in energy metabolism as the NAD+/NADH pair and is consumed as a substrate by three enzyme families: sirtuins (SIRT1–7, which regulate gene expression and mitochondrial function), PARPs (which repair DNA) and CD38 (an NAD-degrading enzyme whose activity rises with age and inflammation).

Animal research and some human tissue studies show NAD+ levels fall with age, and raising NAD+ in animals improves several markers of metabolic health. That is the scientific basis for “sirtuin activation” marketing. The gap is that very little human data show IV NAD+ raises NAD+ inside human tissues or changes clinical outcomes.

A small 2019 pilot study that infused 750 mg over six hours found plasma NAD+ did not rise for the first two hours, while urinary metabolites increased, which suggests rapid uptake or breakdown. Extracellular NAD+ is largely broken down to smaller precursors (nicotinamide mononucleotide, nicotinamide riboside, nicotinamide) before cells take it up.

Regulatory status. NAD+ for injection is not an FDA-approved drug product. Clinics obtain it from 503A pharmacies on patient-specific prescriptions or from 503B outsourcing facilities. Its status as a bulk substance for compounding has been under FDA review, so confirm the current position with your pharmacy before ordering.

NAD+ is also marketed for addiction recovery and withdrawal. Evidence for that use is anecdotal; a person in active alcohol or opioid withdrawal needs medically supervised detoxification, not a wellness drip.

Carrier fluid and dilution

Most protocols dilute NAD+ in 0.9% Sodium Chloride, which is compatible and keeps the final bag close to isotonic. Because NAD+ itself adds very little osmolarity, carrier volume is chosen for rate control and patient fluid tolerance, not to dilute a hypertonic load.

  • 250 mg: commonly 250 mL NS.
  • 500 mg: 250–500 mL NS.
  • 750–1,000 mg: 500–1,000 mL NS, which spreads the dose over a longer drip.

Lactated Ringer’s is used by some practices, but compatibility data for compounded NAD+ in LR are thinner; follow the compounding pharmacy’s stated diluent. Sterile water is not used as an NAD+ carrier. For the electrolyte differences between carriers, see Normal Saline vs Lactated Ringer’s.

NAD+ vials are typically stored refrigerated and protected from light, and the beyond-use date is set by the pharmacy. Mobile nurses need a monitored medical refrigerator in the vehicle; the cold-chain storage guide covers data loggers and temperature excursions.

Infusion rate and titration protocol

NAD+ is rate-limited by symptoms rather than by osmolarity. Infused too fast, it commonly causes chest tightness or pressure, abdominal cramping, nausea, flushing, headache, and a restless or anxious feeling. These effects usually ease within minutes of slowing or pausing the drip. One proposed explanation is adenosine signaling from NAD+ breakdown products, though the mechanism is not settled.

DoseTypical carrierTypical durationAverage rate
250 mg250 mL NS60–120 min≈ 2–4 mg/min
500 mg250–500 mL NS2–3 hours≈ 3–4 mg/min
750 mg500 mL NS3–4 hours≈ 3–4 mg/min
1,000 mg500–1,000 mL NS3.5–4+ hours, sometimes split across two days≈ 4 mg/min

Average rates are derived from common session lengths; they are not a dosing standard. The medical director’s written protocol governs.

How titration usually works

  1. Start at the slowest rate for the first 15–20 minutes while watching for early symptoms.
  2. Step the rate up gradually if the patient is comfortable, using an infusion pump or rate-controlled tubing where available.
  3. At the first report of chest pressure, cramping or nausea, slow or pause, reassess vital signs, and restart at a lower rate once symptoms resolve.
  4. Recheck blood pressure, heart rate and SpO₂ at baseline, about every 30 minutes, and at the end.
When chest symptoms are not the rate. Chest pain that persists after the drip is paused, or comes with shortness of breath, sweating or an abnormal pulse, is treated as a possible cardiac event. Stop the infusion and follow the emergency standing orders, including calling 911.

Glutathione co-administration

Many clinics offer a glutathione push at the end of an NAD+ session. Glutathione is not added to the NAD+ bag: compatibility data for the two in one bag are lacking, and glutathione’s free thiol group oxidizes readily. Instead, the nurse flushes the line with saline after the NAD+ bag finishes, then gives 600–2,000 mg of glutathione as a slow push over several minutes or as a small piggyback. Details are on the glutathione IV push page.

Patients sometimes ask for a Myers’ or other vitamin bag on the same day. That is usually given before or after the NAD+ bag rather than mixed with it, and the total visit length grows accordingly.

Session and package pricing

NAD+ prices reflect two things: the cost of the compounded drug, and two to four hours of a registered nurse’s chair time. National ranges are $375–$850 in a lounge and $450–$1,100 for mobile concierge, where the nurse stays in your home or hotel room for the whole infusion.

Clinics commonly sell loading series (for example four to ten sessions over a few weeks) at a per-session discount, followed by monthly maintenance. There is no clinical standard for how many sessions anyone needs, so treat a package as a pricing decision, not a medical prescription. Check whether unused sessions are refundable.

Use the NAD+ configurator to compare 250, 500, 750 and 1,000 mg sessions in your state.

Who it is for and who it is not for

The typical NAD+ client is a healthy adult interested in energy, focus or healthy-aging protocols who can sit for several hours. Patients new to NAD+ often start at 250 mg to learn how they tolerate the rate before moving to higher doses.

Oral precursors such as nicotinamide riboside and nicotinamide mononucleotide are a lower-cost alternative that have more published human pharmacokinetic data than IV NAD+, though outcome evidence for them is also limited.

Not a fit without physician clearance: pregnancy or breastfeeding (no safety data), recent heart attack, unstable angina or arrhythmia, uncontrolled high blood pressure, active cancer treatment, severe liver or kidney disease, or anyone in alcohol or drug withdrawal.

Lounge vs. mobile price benchmarks

2025–2026 U.S. self-pay benchmarks for NAD+ by dose (indicative ranges within national data)
Setting / doseTypical priceWhat is includedNotes
Lounge, 250 mg$375–$450NAD+ in 250 mL NS, 1–2 hours of monitoringCommon first session
Lounge, 500 mg$500–$6502–3 hours, titratedMost common maintenance dose
Lounge, 750–1,000 mg$650–$8503–4+ hoursSome clinics split 1,000 mg across two visits
Mobile concierge, any dose$450–$1,100Nurse remains on site for the full infusionPrice scales with chair time; trip fees may apply
Glutathione push add-on+$35–$65600–2,000 mg after the NAD+ bagSeparate syringe, line flushed first
Loading series / packageOften 10–20% off per sessionPrepaid block of sessionsNo clinical standard for session count

Prices are national self-pay medians; the drip configurator applies your state’s regional index, add-ons and group tiers.

Mandatory screening & contraindications

Required before the infusion

  • Good Faith Exam by an MD, DO, NP or PA before the first infusion and when health history changes
  • Cardiac history: chest pain, heart attack, arrhythmia, uncontrolled hypertension
  • Medication review, including chemotherapy and other investigational or compounded products
  • Pregnancy and breastfeeding status
  • Vital signs at baseline, about every 30 minutes, and at discharge
  • Confirmation that the NAD+ vial is within its beyond-use date and was stored cold
  • Advice to eat beforehand and stay hydrated, which many protocols use to reduce nausea

Contraindications & stop signals

  • Absolute: prior severe reaction to NAD+
  • Absolute: pregnancy or breastfeeding (no safety data)
  • Absolute: unstable angina, recent myocardial infarction or uncontrolled arrhythmia
  • Relative: active cancer or cancer treatment (theoretical concern about supporting tumor metabolism; oncologist input required)
  • Relative: uncontrolled hypertension or significant anxiety or panic disorder (rate symptoms can mimic panic)
  • Relative: severe hepatic or renal impairment
  • Relative: heart failure or fluid restriction (limit carrier volume)

Configure this protocol for your group or event

Choose mobile or lounge, volume, add-ons and participants; the estimate, safety flags and printable brief update instantly and carry into your booking request.

Where this protocol is in demand

NAD+ bookings concentrate in high-income executive and longevity markets with dense hotel and in-home concierge demand.

For clinics offering this drip: FDA Section 503A vs 503B Outsourcing Facilities: Sourcing Sterile IV Nutrients Legally · Cold-Chain Logistics & Medication Storage in Mobile IV Vehicles · Clinical Standing Orders, Inclusion and Exclusion Criteria, and Emergency Protocols for Mobile IV.

Frequently asked questions

Why does an NAD+ IV take so long?

Fast infusion causes chest pressure, cramping and nausea, so NAD+ is dripped slowly and titrated to comfort. A 500 mg dose usually takes two to three hours and 1,000 mg can take four hours or more.

What does NAD+ feel like during the infusion?

Many people feel nothing at a slow rate. If the rate is too fast, common sensations are chest tightness, stomach cramping, flushing, headache or restlessness, which usually fade within minutes when the nurse slows the drip.

Is NAD+ IV FDA-approved?

No. NAD+ for injection is a compounded preparation with no FDA-approved indication. Clinics source it from 503A or 503B pharmacies, and claims about longevity or addiction treatment are not supported by strong human trials.

How many NAD+ sessions do I need?

There is no evidence-based number. Clinics often sell loading series followed by monthly sessions, but those schedules are commercial conventions rather than clinical standards.

Can NAD+ be mixed with glutathione in one bag?

Most protocols keep them separate. The nurse finishes the NAD+ bag, flushes the line, then pushes glutathione slowly, because data on mixing the two are lacking and glutathione oxidizes easily.

Is IV NAD+ better than oral NR or NMN?

That has not been shown. Oral precursors have more published data on raising blood NAD+ levels and cost far less, while IV NAD+ is largely broken down outside cells before uptake.

Sources & standards reviewed

  1. Grant R, et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience, 2019 Frontiers
  2. Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metabolism, 2018 Cell Press
  3. Bulk drug substances used in compounding under Section 503A and 503B of the FD&C Act U.S. Food and Drug Administration
  4. USP General Chapter <797> Pharmaceutical Compounding—Sterile Preparations USP
  5. Infusion Therapy Standards of Practice Infusion Nurses Society

Reviewed under the IVConnection clinical and regulatory review policy. Report a correction to clinical@ivconnection.com.

Related protocols